MariMed Inc.
MRMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $26,903 | $35,960 | $43,546 |
| - Cash | $6,596 | $5,938 | $7,001 | $7,282 |
| + Debt | $79,869 | $87,028 | $87,514 | $88,467 |
| Enterprise Value | – | $107,993 | $116,473 | $124,731 |
| Revenue | $40,764 | $39,611 | $37,955 | $39,002 |
| % Growth | 2.9% | 4.4% | -2.7% | – |
| Gross Profit | $16,363 | $16,032 | $15,138 | $12,709 |
| % Margin | 40.1% | 40.5% | 39.9% | 32.6% |
| EBITDA | $4,432 | $4,266 | $1,929 | $1,677 |
| % Margin | 10.9% | 10.8% | 5.1% | 4.3% |
| Net Income | -$2,948 | -$1,269 | -$5,452 | -$8,204 |
| % Margin | -7.2% | -3.2% | -14.4% | -21% |
| EPS Diluted | -0.01 | -0.003 | -0.014 | -0.022 |
| % Growth | -203% | 76.9% | 33.5% | – |
| Operating Cash Flow | $2,676 | $297 | $1,293 | -$413 |
| Capital Expenditures | -$314 | -$554 | -$266 | -$1,107 |
| Free Cash Flow | $2,362 | -$257 | $1,027 | -$1,520 |